natgillin/translations-raw huggingface dataset:
The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product. 
Pomoćne tvari (uključujući adjuvanse), navedene u dijelu 6.1 SPC su ili dozvoljene tvari za koje je u tablici 1, Dodatka Uredbe Komisije (EU) br. 37/2010 navedeno da određivanje MRL nije nužno ili se smatra da se na njih ne primjenjuju odredbe Uredbe (EK) br. 470/2009 kada se primjenjuju u tim veterinarsko medicinskim proizvodima.
C/ Mocholi 2, Poligono Industrial Mocholi, Noain, 31110 Navarra SPAIN 
C/ Mocholi 2, Poligono Industrial Mocholi, Noain, 31110 Navarra, ŠPANJOLSKA
Shake gently to give a clear solution, and administer immediately the entire content (0.5 ml) of the reconstituted product. 
Blago promućkati dok se otopina ne razbistri i odmah aplicirati cijeli sadržaj (0,5 ml) rekonstituiranog proizvoda.
Onset of immunity: 4 weeks after vaccination. 
Početak imunosti: 4 tjedna nakon cijepljenja.
1 vial of lyophylisate and 1 vial of solvent (1 dose) 4 vials of lyophylisate and 4 vials of solvent (4 doses) 5 vials of lyophylisate and 5 vials of solvent (5 doses) 10 vials of lyophylisate and 10 vials of solvent (10 doses) 20 vials of lyophylisate and 20 vials of solvent (20 doses) 25 vials of lyophylisate and 25 vials of solvent (25doses) 50 vials of lyophylisate and 50 vials of solvent (50 doses) 100 vials of lyophylisate and 100 vials of solvent (100 doses) 
1 bočica liofilizata i 1 bočica otapala (1 doza) 4 bočice liofilizata i 4 bočice otapala (4 doze) 5 bočica liofilizata i 5 bočica otapala (5 doza) 10 bočica liofilizata i 10 bočica otapala (10 doza) 20 bočica liofilizata i 20 bočica otapala (20 doza) 25 bočica liofilizata i 25 bočica otapala (25 doza) 50 bočica liofilizata i 50 bočica otapala (50 doza) 100 bočica liofilizata i 100 bočica otapala (100 doza)
QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.5 ml vaccine contains: 
KVALITATIVNI I KVANTITATIVNI SASTAV Svaka doza od 0,5 ml cjepiva sadrži:
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009. 
Djelatna tvar se sastoji od tvari biološkog podrijetla, koje su namijenjene je za stvaranje aktivne imunosti i na koje se ne primjenjuju odredbe Uredbe (EK) br. 470/2009.
White lyophilisate. 
Bijeli liofilizat.
Each dose of 0.5 ml vaccine contains: 
Svaka doza od 0,5 ml cjepiva sadrži:
Following administration of a double dose, reactions are similar in nature to those observed following the administration of a single dose (see section 4.6). 
Nakon primjene dvostruke doze cjepiva, reakcije su slične onima koje su opažene nakon primjene jedne doze cjepiva (vidi odjeljak 4.6).
To stimulate active immunity against disease caused by Leishmania infantum parasites. 
Za stimuliranje aktivnog imuniteta protiv oboljenja uzrokovanog parazitom Leishmania infantum.
QUANTITY OF THE ACTIVE SUBSTANCE(S) CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER OF DOSES 
KOLIČINA DJELATNE(IH) TVARI SADRŽAJ PO TEŽINI, VOLUMENU ILI BROJU DOZA
No efficacy has been demonstrated in these animals. 
Kod ovih životinja nije se pokazala učinkovitost cjepiva.
The manufacture, import, possession, sale, supply and/or use of LETIFEND may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation. 
Proizvodnja, uvoz, posjedovanje, prodaja, opskrba i/ili primjena LETIFEND je ili može biti zabranjena u državi članici na cijelom ili na dijelu njene teritorije sukladno nacionalnim propisima.
via Fratelli Cervi snc, Centro Direzionale Milano Due, Palazzo Canova 
MSD Animal Health S.r.l. via Fratelli Cervi snc, Centro Direzionale Milano Due, Palazzo Canova
Therefore, the use is not recommended during pregnancy and lactation. 
Stoga, ne preporuča se primjena tijekom graviditeta i laktacije.
For active immunisation of non-infected dogs from 6 months of age to reduce the risk of developing an active infection and/or clinical disease after exposure to Leishmania infantum. 
Za aktivnu imunizaciju neinficiranih pasa od 6 mjeseci starosti radi smanjenja rizika od razvitka aktivne infekcije i/ili kliničkog oboljenja nakon kontakta s Leishmania infantum.
Sodium chloride Arginine hydrochloride Boric acid. 
Liofilizat: natrijev klorid arginin hidroklorid borna kiselina.
Recombinant Protein Q from Leishmania infantum MON-1: ≥ 36.7 ELISA units (EU)* * Antigen content determined in an ELISA against an internal standard. 
Rekombinirana bjelančevina Q iz Leishmania infantum MON-1 : ≥ 36,7 ELISA jedinica (EU)* * Sadržaj antigena određen ELISA testom prema internom standardu.
Pharmacotherapeutic group: Immunologicals for Canidae - dog - inactivated parasitic vaccinesleishmania. 
Farmakoterapijska grupa: imunološki proizvodi za Canidae - pse - inaktivirano cjepivo protiv parazita - leishmania.
The vaccine is safe in infected dogs. 
Cjepivo je sigurno za inficirane pse.
Diagnostic tools designed to detect Leishmania antibodies (SLA or IFAT or rk-39 rapid diagnostic tests) should be suitable to enable discrimination between dogs vaccinated with this vaccine and dogs infected with Leishmania infantum. 
Dijagnostički alati osmišljeni za otkrivanje protutijela na Leishmania (SLA ili IFAT ili rk-39 brzi dijagnostički testovi) omogućuju razlikovanje cijepljenih pasa od pasa zaraženih s Leishmania infantum.
Recombinant Protein Q from Leishmania infantum MON-1 
Rekombinirana bjelančevina Q iz Leishmania infantum MON-1
Lyophilisate (white lyophilisate) 
Liofilizat (bijeli liofilizat)
Any person intending to manufacture, import, possess, sell, supply and use LETIFEND must consult the relevant Member State's competent authority on the current vaccination policies prior to the manufacture, import, possession, sale, supply and/or use. 
Tko namjerava proizvoditi, uvesti, posjedovati, prodavati, opskrbljivati i/ili primjenjivati LETIFEND mora se savjetovati s nadležnim tijelom odnosne države članice u pogledu važećih odredbi o cijepljenju prije proizvodnje, uvoza, posjedovanja, prodaje, opskrbe i/ili primjene.
Vials are both closed with a bromobutyl stopper and an aluminium cap. 
Obje bočice zatvorene su bromobutil čepom i zapečaćene aluminijskom kapicom.
Following administration of a double dose, reactions are similar in nature to those observed following the administration of a single dose. 
Nakon primjene dvostruke doze cjepiva, reakcije su slične onima koje su opažene nakon primjene jedne doze cjepiva.
Per dose of 0.5 ml: Recombinant Protein Q from Leishmania infantum MON-1 ≥ 36.7 EU 
Po dozi od 0,5 ml: Rekombinirana bjelančevina Q iz Leishmania infantum MON-1 ≥ 36,7 EU
EXP {mm/yyyy} Once reconstituted use immediately. 
EXP {mm/gggg} Primijeniti odmah nakon rekonstitucije.
WITHDRAWAL PERIOD(S) SPECIAL WARNING(S), IF NECESSARY 
POSEBNO(A) UPOZORENJE(A), UKOLIKO JE POTREBNO
In laboratory studies including experimental challenge with Leishmania infantum, the vaccine reduced the severity of the disease, including clinical signs and parasite burden in spleen and lymph nodes. 
U laboratorijskim ispitivanjima u kojima su životinje bile izložene Leishmania infantum, cjepivo je umanjilo simptome oboljenja, uključujući i kliničku sliku i količinu parazita u slezeni i limfnim čvorovima.
Water for injections. 
Otapalo: voda za injekcije.
Shelf life of the solvent: 5 years. 
Rok valjanosti otapalo: 5 godine.
Primary vaccination scheme: A single dose of the vaccine (0.5 ml) to be administered to dogs from 6 months of age. 
Primarna shema cijepljenja: Jedna doza cjepiva (0,5 ml) primjenjuje se psima starijim od 6 mjeseci.
Method of administration: 
Metoda primjene:
A test for the detection of Leishmania infection is recommended prior to vaccination. 
Prije cijepljenja preporučuje se test za otkrivanje infekcije parazitom Leishmania.
6.5 Nature and composition of immediate packaging Lyophilisate vial 
6.5 Osobine i sastav unutarnjeg pakovanja
BATCH NUMBER Lot {number} EXPIRY DATE EXP {mm/yyyy} THE WORDS “FOR ANIMAL TREATMENT ONLY” For animal treatment only. 
BROJ PROIZVODNE SERIJE Lot {broj} ROK VALJANOSTI EXP {mm/gggg} RIJEČI „SAMO ZA PRIMJENU NA ŽIVOTINJAMA“
Solvent Water for injections: q.s. 
Otapalo voda za injekcije q.s. 0,5 ml.
Do not mix with any other veterinary medicinal product, except solvent supplied for use with the veterinary medicinal product. 
Ne miješati s bilo kojim drugim veterinarsko-medicinskim proizvodom, osim otapalom priloženim za primjenu s veterinarsko-medicinskim proizvodom.
After vaccination, scratching at the injection site has been observed very commonly in dogs. 
Poslije cijepljenja kod pasa je vrlo često primijećeno češanje mjesta uboda.
The efficacy of the vaccine was demonstrated in a field study where seronegative dogs from a variety of breeds were naturally exposed to Leishmania infantum in zones with high infection pressure over a two year period. 
Učinkovitost cjepiva dokazana je ispitivanjem na terenu gdje su seronegativni psi različitih pasmina, u razdoblju od dvije godine, bili prirodno izloženi uzročniku Leishmania infantum u područjima gdje postoji velika mogućnost zaraze.
De-worming of infested dogs prior to vaccination is recommended. 
Prije cijepljenja preporuča se dehelmintizacija zaraženih pasa.
The efficacy of the vaccine was demonstrated in a field study where dogs were naturally exposed to Leishmania infantum in zones with high infection pressure over a two year period. 
Učinkovitost cjepiva dokazana je ispitivanjem na terenu gdje su psi, u razdoblju od dvije godine, bili prirodno izloženi uzročniku Leishmania infantum u područjima gdje postoji velika mogućnost zaraze.
Re-vaccination scheme: A single dose of the vaccine (0.5 ml) to be given annually thereafter. 
Ponovno cijepljenje: Jedna doza cjepiva (0,5 ml) godišnje za ponovno cijepljenje.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial of lyophilisate 
OSNOVNI PODACI KOJI SE MORAJU NALAZITI NA MALIM UNUTARNJIM PAKOVANJIMA
Laboratorios LETI, S.L.unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 
Laboratorios LETI, S.L. unipersonal C/ Del Sol, 5, Poligono Industrial Norte, Tres Cantos
Shelf life after reconstitution according to directions: use immediately Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP. 
Ne koristite veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na etiketi poslije EXP.
Lyohilisate: 
Liofilizat:
20 doses 
20 doza
Reconstitute one vial of the white lyophilisate using 0.5 ml of the solvent. 
Rekonstituirati jednu bočicu bijelog liofilizata s 0,5 ml otapala.
MANUFACTURER RESPONSIBLE FOR BATCH RELEASE Name and address of the manufacturer of the biological active substance 
Naziv i adresa proizvođača biološki djelatne tvari
It is essential that measures to reduce exposure to sand-flies are employed in vaccinated animals. 
Neophodno je kod cijepljenih životinja primijeniti mjere za smanjenje izloženosti papataču.
NAME OF THE VETERINARY MEDICINAL PRODUCT LETIFEND lyophilisate for dogs 
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA LETIFEND liofilizat za pse
A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND 
PROIZVOĐAČ BIOLOŠKI DJELATNE TVARI I PROIZVOĐAČ ODGOVORAN ZA
NAME OF THE VETERINARY MEDICINAL PRODUCT LETIFEND, lyophilisate and solvent for solution for injection for dogs 
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA LETIFEND, liofilizat i otapalo za otopinu za injekciju za pse
Lyophilisate and solvent for solution for injection. 
Liofilizat i otapalo za otopinu za injekciju.
≥ 36.7 ELISA Units (EU)* * Antigen content determined in an ELISA against an internal standard. 
≥ 36,7 ELISA jedinica (EU)*
LETIFEND, lyophilisate and solvent for solution for injection for dogs. 
LETIFEND, liofilizat i otapalo za otopinu za injekciju za pse.
PHARMACEUTICAL FORM Lyophilisate and solvent for solution for injection. 
OBLIK Liofilizat i otapalo za otopinu za injekciju.
Laboratorios LETI, S.L.unipersonal C/ Del Sol, 5, Poligono Industrial Norte, Tres Cantos, 28760, Madrid SPAIN 
Laboratorios LETI, S.L. unipersonal C/ Del Sol, 5, Poligono Industrial Norte, Tres Cantos, 28760, Madrid ŠPANJOLSKA
QUANTITY OF THE ACTIVE SUBSTANCE(S) Recombinant Protein Q from L. infantum MON-1 
KOLIČINA DJELATNE(IH) TVARI Rekombinirana bjelančevina Q iz L. infantum MON-1 SADRŽAJ PO TEŽINI, VOLUMENU ILI BROJU DOZA 1 doza
Type I glass vials containing 0.8 ml of solvent. 
I koja sadrži 0,8 ml otapala.
LETIFEND, lyophilisate and solvent for solution for injection for dogs 
LETIFEND, liofilizat i otapalo za otopinu za injekciju za pse
Plastic box containing 4 vials of 1 dose of lyophilisate and 4 vials of 0.8 ml of solvent. 
Plastična kutija s 4 bočice s 1 dozom liofilizata i 4 bočice s 0,8 ml otapala.
Plastic box containing 25 vials of 1 dose of lyophilisate and 25 vials of 0.8 ml of solvent. 
Plastična kutija s 25 bočica s 1 dozom liofilizata i 25 bočica s 0,8 ml otapala.
Plastic box containing 20 vials of 1 dose of lyophilisate and 20 vials of 0.8 ml of solvent. 
Plastična kutija s 20 bočica s 1 dozom liofilizata i 20 bočica s 0,8 ml otapala.
Plastic box containing 100 vials of 1 dose of lyophilisate and 100 vials of 0.8 ml of solvent. 
Plastična kutija sa 100 bočica s 1 dozom liofilizata i 100 bočica s 0,8 ml otapala.
PACKAGE LEAFLET: LETIFEND, lyophilisate and solvent for solution for injection for dogs 
UPUTA O VMP: LETIFEND, liofilizat i otapalo za otopinu za injekciju za pse
Plastic box containing 5 vials of 1 dose of lyophilisate and 5 vials of 0.8 ml of solvent. 
Plastična kutija s 5 bočica s 1 dozom liofilizata i 5 bočica s 0,8 ml otapala.
Plastic box containing 50 vials of 1 dose of lyophilisate and 50 vials of 0.8 ml of solvent. 
Plastična kutija s 50 bočica s 1 dozom liofilizata i 50 bočica s 0,8 ml otapala.
Plastic box containing 10 vials of 1 dose of lyophilisate and 10 vials of 0.8 ml of solvent. 
Plastična kutija s 10 bočica s 1 dozom liofilizata i 10 bočica s 0,8 ml otapala.
4 doses 
4 doze
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANIEN) 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANYOLORSZÁG)
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANJE) 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ŠPANIELSKO)
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Μαδρίτη (ΙΣΠΑΝΙΑ) Τηλ: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Μαδρίτη (ΙΣΠΑΝΙΑ) Τηλ: + 34 91 771 17 90
Plastic box containing 1 vial of 1 dose of lyophilisate and 1 vial of 0.8 ml of solvent. 
Plastična kutija s 1 bočicom s 1 dozom liofilizata i 1 bočicom s 0,8 ml otapala.
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ESPANJA) Puh/Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ESPANJA) Puh/Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANJE/ESPAGNE/SPANIEN) Tél/Tel: + 34 91 771 17 90 
Luxembourg/Luxemburg Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ESPAGNE/SPANIEN) Tél/Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANIA) Tlf: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANIA) Tlf: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANIEN) Tlf: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANIEN) Tlf: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPÁNN) Sími: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPÁNN) Sími: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madride (SPĀNIJA) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madride (SPĀNIJA) Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madridas (ISPANIJA) Tel: +34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madridas (ISPANIJA) Tel: +34 91 771 17 90
Solvent vial 
Bočica otapala
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ESPAÑA) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ESPAÑA) Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ŠPANĚLSKO) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ŠPANIJA) Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANIA) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANIA) Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ŠPANJOLSKA) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ŠPANJOLSKA) Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (HISPAANIA) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (HISPAANIA) Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPAIN) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPAIN) Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANIEN) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (SPANJE) Tel: + 34 91 771 17 90
unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ESPANHA) Tel: + 34 91 771 17 90 
Laboratorios LETI, S.L. unipersonal C/ Del Sol 5, Polígono Industrial Norte Tres Cantos 28760 Madrid (ESPANHA) Tel: + 34 91 771 17 90
Swelling and redness of eyelid. 
NAVOĐENJE DJELATNE(IH) TVARI
However, no special dose adjustment is needed in these populations. 
Ipak, nisu potrebne posebne prilagodbe doze u ovim populacijama.
In Period 2, analyses demonstrated stability of improvements achieved during Period 1 for both doses regimen. 
U Razdoblju 2 analize su pokazale stabilnost poboljšanja postignutih u Razdoblju 1 za oba režima doziranja.
Tilt your head back and look up at the ceiling 8. 
Nagnite glavu natrag i gledajte u strop
Do not take a double dose to make up for the forgotten dose. 
Nemojte primijeniti dvostruku dozu kako biste nadoknadili zaboravljenu dozu.
Only use Verkazia in your eye as described under section 3. 
Primjenjujte Verkaziu u oko samo kako je opisano u dijelu 3.
Effects on the immune system 
Učinci na imunosni sustav
Mean age was 9.2 years (SD: 3.3, age range: 4-17 years). 
Srednja vrijednost dobi bila je 9,2 godine (SD: 3,3; raspon dobi: 4-17 godina).
Verkazia is likely to be present in breast milk in very small amounts. 
Verkazia će vjerojatno biti prisutna u majčinom mlijeku u vrlo malim količinama.
What Verkazia is and what it is used for 2. 
Što je Verkazia i za što se koristi 2.
By pressing at this point, you close down the opening of this drainage duct. 
Pritiskom na to mjesto zatvarate otvor tog odvodnog kanala.
If you use drops in both eyes, repeat the steps 6 to 9 for your other eye. 12. 
Ako primjenjujete kapi u oba oka, ponovite korake 6 do 9 za drugo oko.
Efficacy and safety of Verkazia have not been studied beyond 12 months. 
Djelotvornost i sigurnost Verkazie nisu ispitivane dulje od 12 mjeseci.
A caregiver should help a child starting Verkazia treatment, particularly if the child is aged under 10 years, and should continue to supervise the child until the child is able to use Verkazia properly without help. 
Djetetu koje počinje primjenjivati Verkaziu treba pomoći njegovatelj, naročito ako je dijete mlađe od 10 godina, te treba nastaviti nadgledati dijete sve dok ono ne bude sposobno pravilno primijeniti Verkaziu bez pomoći.
If signs and symptoms of VKC persist after the end of the season, the treatment can be maintained at the recommended dose or decreased to one drop twice daily once adequate control of signs and symptoms is achieved. 
Ako znakovi i simptomi VKK-a perzistiraju i nakon sezone, liječenje se može nastaviti u preporučenoj dozi ili smanjiti na jednu kap dva puta na dan kada se postigne odgovarajuća kontrola znakova i simptoma.
Children below 4 years 
Djeca mlađa od 4 godine
Do not use Verkazia in children under the age of 4 years. 
Ne primjenjujte Verkaziu u djece mlađe od 4 godine.
Blocking NF-AT also interferes in the allergy process. 
Blokiranje NFAT-a utječe i na alergijske procese.
EXCELVISION 27 rue de la Lombardière ZI la Lombardière 07100 Annonay France 
EXCELVISION 27 rue de la Lombardière ZI la Lombardière 07100 Annonay
What you need to know before you use Verkazia 3. 
Što morate znati prije nego počnete primjenjivati Verkaziu 3.
Talk to your doctor or pharmacist before using Verkazia: - if you have had an eye infection or if you suspect you have an eye infection - if you have any other kind of eye disease - if you wear contact lenses (the use of Verkazia is not recommended with contact lenses). 
Obratite se svom liječniku ili ljekarniku prije nego primijenite Verkaziu: - ako ste imali infekciju oka ili sumnjate da imate infekciju oka - ako imate bilo kakvu drugu vrstu očne bolesti - ako nosite kontaktne leće (ne preporučuje se primjena Verkazie uz kontaktne leće).
Keep single-dose containers in the pouch in order to protect from light and avoid evaporation. 
Jednodozne spremnike čuvati u vrećici radi zaštite od svjetlosti i izbjegavanja isparavanja.
Verkazia is not recommended during pregnancy unless the potential benefit to the mother outweighs the potential risk to the foetus. 
Ne preporučuje se koristiti lijek Verkazia tijekom trudnoće, osim ako moguća korist za majku ne nadmašuje mogući rizik za fetus.
If you stop using Verkazia without speaking to your doctor, your eye allergy will not be controlled and could lead to long-term problems with your sight. 
Ako prestanete primjenjivati Verkaziu bez savjetovanja sa svojim liječnikom, očna alergija više se neće kontrolirati i može doći do dugotrajnih problema s vidom.
Ciclosporin reduces the activity of the body's immune (defence) system and in this way it reduces inflammation (body response to harmful stimuli). 
Ciklosporin smanjuje aktivnost imunosnog (obrambenog) sustava tijela i na taj način smanjuje upalu (odgovor tijela na štetni podražaj).
Blink a few times so that the medicine spreads across your eye 10. 
Trepnite nekoliko puta kako bi se lijek raširio po oku.
Contents of the pack and other information What Verkazia contains 
Sadržaj pakiranja i druge informacije Što Verkazia sadrži
A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Verkazia therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman. 
Potrebno je odlučiti da li prekinuti dojenje ili prekinuti liječenje/suzdržati se od liječenja lijekom Verkazia uzimajući u obzir korist dojenja za dijete i korist liječenja za ženu.
There were more male [n=132 (78.6%)] than female patients [n=36 (21.4%)]. 
Bilo je više bolesnika [n=132 (78,6 %)] nego bolesnica [n=36 (21,4 %)].
If you are using other eye drops, use Verkazia at least 15 minutes after using the other eye drops. 
Ako koristite druge kapi za oko, Verkaziu primijenite najmanje 15 minuta nakon korištenja drugih kapi za oko.